Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CofaceCFACY -4.13%54 3-Year EBITDA Growth Rate is -2.80% as of Mar. 2026. GuruFocus rates CFACY with a GF Score™ of 54/100 and a GF Value™ of $18.99 (Fairly Valued). The stock has 5 warning signs investors should review. Among 293 Insurance companies, Coface ranks worse than 83.96% on this metric.
During the past 12 months, Coface's average EBITDA Per Share Growth Rate was -17.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -2.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 12.90% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Coface was 30.10% per year. The lowest was -13.20% per year. And the median was 5.95% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Coface 3-Year EBITDA Growth Rate Related Terms
CFACY vs RGA, EG, RNR: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Reinsurance subindustry, Coface's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coface 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Coface's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Coface's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -2.80% mean?
Coface (CFACY) has a 3-Year EBITDA Growth Rate of -2.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Coface and its competitors. According to the industry distribution chart, Coface ranks #246 out of 293 companies in the Insurance industry, placing it in the top 84%.
Is Coface's 3-Year EBITDA Growth Rate too high?
Coface's current 3-Year EBITDA Growth Rate is -2.80%. Based on the distribution chart, Coface ranks #246 out of 293 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Coface has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coface's 3-Year EBITDA Growth Rate compare to RGA and EG?
According to the Insurance industry distribution chart, Coface ranks #246 out of 293 companies for 3-Year EBITDA Growth Rate. This places Coface in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 17.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 17.20, based on 293 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Coface and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 17.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coface's current 3-Year EBITDA Growth Rate is -2.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coface stock overvalued right now?
Based on GuruFocus' analysis, Coface (CFACY) is currently considered Fairly Valued. The stock's GF Value™ is $18.99, compared to a current price of $17.90 — trading 5.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -2.80%. Coface's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Coface (CFACY), the current 3-Year EBITDA Growth Rate is -2.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coface (CFACY) Overvalued in 2026?
Based on GuruFocus' analysis, Coface stock appears to be undervalued.
The current stock price of $17.90 is trading 5.8% below its estimated GF Value™ of $18.99.
GuruFocus considers Coface to be Fairly Valued.
Key valuation signals for CFACY:
3-Year EBITDA Growth Rate: -2.80%
GF Value™: $18.99 vs. price of $17.90 (5.8% below fair value)
No single metric tells the full story. See the CFACY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coface SA is a property and casualty insurance company. The vast majority of its revenue is generated by its group reinsurance business. Majority of the company's sales are generated in Europe. The company offers credit insurance products to protect companies against potentially uncollected payments from their customers. Coface's plan focuses on risk management. The company considers merger and acquisition investment as a component of its operational growth Plan..
54GF Score
Get the complete analysis for CFACY
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CFACY has been successfully added to your 
